OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1.
Posted by rob on December 25, 2010 under Uncategorized | 
Comments are off for this article
OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1.
Leukemia. 2010 Nov;24(11):1962-5
Authors: White DL, Saunders VA, Dang P, Engler J, Hughes TP
PMID: 20811406 [PubMed - indexed for MEDLINE]